Humanigen Inc (fka HGENQ)

[cowtown jay]

Since you asked, I think Durrant will merge one of his Taran entities into the hollowed-out Humanigen subsidiary, and that newly-formed entity will become the parent company of Humanigen.

How he may shuffle the deck, including his other Taran entity (the one without control of our product pipeline), and the remaining Humanigen subsidiaries, is anyone's guess. He may look at dedicating the other subsidiaries to specific medical fields, because I see wide open spaces to focus on beyond covid and oncology, as I recently noted in regards to MS and malaria, and then look to enter into further partnerships to advance those opportunities.

In addition, we have long-standing partnership interests in fields such as arthritis and asthma, which are mature markets, but they are large, and as it does, lenz will possibly revolutionize the treatment of those indications, giving us huge opportunity in these developed areas.

I am not only entirely comfortable with this investment, I am excited to see how much more value Durrant and Dale will bring to Humanigen's shareholders.

Thank you for the question.